These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 2438335)

  • 1. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity.
    Ozaki S; Berzofsky JA
    J Immunol; 1987 Jun; 138(12):4133-42. PubMed ID: 2438335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.
    Abbas AK; Haber S; Rock KL
    J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
    Casten LA; Pierce SK
    J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic activity of antigen receptors artificially incorporated onto B lymphocytes.
    Peacock JS; Londo TR; Roess DA; Barisas BG
    J Immunol; 1986 Sep; 137(6):1916-23. PubMed ID: 2427584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of antigen-specific and MHC-restricted B cell hybridoma clones: a model for studying antigen presentation to T cell lines and clones.
    Zimecki M; Kapp JA; Pierce CW
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):395-408. PubMed ID: 2471476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The requirement for surface Ig signaling as a prerequisite for T cell:B cell interactions. A possible role for desialylation.
    Kearse KP; Cassatt DR; Kaplan AM; Cohen DA
    J Immunol; 1988 Mar; 140(6):1770-8. PubMed ID: 3126236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted antigen presentation using crosslinked antibody heteroaggregates.
    Snider DP; Segal DM
    J Immunol; 1987 Sep; 139(5):1609-16. PubMed ID: 2957430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR; Subbarao B
    J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
    Zhang YP; Tzartos SJ; Wekerle H
    Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
    Whalen BJ; Tony HP; Parker DC
    J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific B cells efficiently present low doses of antigen for induction of T cell proliferation.
    Malynn BA; Romeo DT; Wortis HH
    J Immunol; 1985 Aug; 135(2):980-8. PubMed ID: 2409164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation by liposomes as model system for T-B cell interaction.
    Walden P
    Eur J Immunol; 1988 Nov; 18(11):1851-4. PubMed ID: 3264532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
    DeKruyff R; Clayberger C; Cantor H; Dorf ME
    J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.
    Janeway CA; Ron J; Katz ME
    J Immunol; 1987 Feb; 138(4):1051-5. PubMed ID: 3100626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antigen processing and presentation by resting B lymphocytes.
    Gosselin EJ; Tony HP; Parker DC
    J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin-specific T-B cell interaction. I. Presentation of self immunoglobulin determinants by B lymphocytes.
    Rudensky AY; Yurin VL
    Eur J Immunol; 1989 Sep; 19(9):1677-83. PubMed ID: 2477255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
    Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
    J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.